Form S-3 Kyverna Therapeutics,

Go back to Form S-3 Kyverna Therapeutics,

Kyverna Therapeutics (KYTX) Files $250M Mixed Shelf

March 27, 2025 4:53 PM EDT

Kyverna Therapeutics (NASDAQ: KYTX) has filed $250,000,000 mixed shelf of:

Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
Depositary Shares

... More